254 related articles for article (PubMed ID: 11995475)
1. Serum interleukin-6 and hepatocyte growth factor levels in patients after hepatectomy.
Chijiiwa K; Saiki S; Tanaka M
Hepatogastroenterology; 2002; 49(44):467-71. PubMed ID: 11995475
[TBL] [Abstract][Full Text] [Related]
2. Enhanced inflammatory cytokine production at ischemia/reperfusion in human liver resection.
Kim YI; Song KE; Ryeon HK; Hwang YJ; Yun YK; Lee JW; Chun BY
Hepatogastroenterology; 2002; 49(46):1077-82. PubMed ID: 12143206
[TBL] [Abstract][Full Text] [Related]
3. Portal serum human hepatocyte growth factor levels after partial hepatectomy.
Higaki I; Yamazaki O; Matsuyama M; Horii K; Kawai S; Hirohashi K; Kinoshita H
Hepatogastroenterology; 1999; 46(26):1078-82. PubMed ID: 10370670
[TBL] [Abstract][Full Text] [Related]
4. Clarification of risk factors for hepatectomy in patients with hepatocellular carcinoma.
Ishikawa M; Yogita S; Miyake H; Fukuda Y; Harada M; Wada D; Tashiro S
Hepatogastroenterology; 2002; 49(48):1625-31. PubMed ID: 12397750
[TBL] [Abstract][Full Text] [Related]
5. The clinical value of hepatocyte growth factor and its receptor--c-met for liver cancer patients with hepatectomy.
Wu F; Wu L; Zheng S; Ding W; Teng L; Wang Z; Ma Z; Zhao W
Dig Liver Dis; 2006 Jul; 38(7):490-7. PubMed ID: 16627020
[TBL] [Abstract][Full Text] [Related]
6. Serum hepatocyte growth factor before and after resection for hepatocellular carcinoma.
Hu RH; Lee PH; Yu SC; Sheu JC; Lai MY
Hepatogastroenterology; 1999; 46(27):1842-7. PubMed ID: 10430357
[TBL] [Abstract][Full Text] [Related]
7. Serum alkaline phosphatase after extensive liver resection: a study in patients with biliary tract carcinoma.
Nagino M; Nimura Y; Kamiya J; Kanai M; Uesaka K; Hayakawa N; Yamamoto H
Hepatogastroenterology; 1999; 46(26):766-70. PubMed ID: 10370608
[TBL] [Abstract][Full Text] [Related]
8. Correlation between human hepatocyte growth factor and interleukin-6 concentrations after surgery.
Kimura F; Miyazaki M; Suwa T; Kadoyama C; Itoh H; Ambiru S; Shimizu H; Nakagawa K
Hepatogastroenterology; 1999; 46(26):1030-5. PubMed ID: 10370662
[TBL] [Abstract][Full Text] [Related]
9. Increased levels of human hepatocyte growth factor in serum and peritoneal fluid after partial hepatectomy.
Kimura F; Miyazaki M; Suwa T; Kakizaki S; Itoh H; Kaiho T; Ambiru S; Shimizu H; Togawa A
Am J Gastroenterol; 1996 Jan; 91(1):116-21. PubMed ID: 8561110
[TBL] [Abstract][Full Text] [Related]
10. Human hepatocyte growth factor in bile: an indicator of posthepatectomy liver function in patients with biliary tract carcinoma.
Takeuchi E; Nimura Y; Nagino M; Kurumiya Y; Maeda A; Kamiya J; Kondo S; Kanai M; Miyachi M; Uesaka K; Yoshida S
Hepatology; 1997 Nov; 26(5):1092-9. PubMed ID: 9362347
[TBL] [Abstract][Full Text] [Related]
11. The role of a protease inhibitor against hepatectomy.
Gotohda N; Iwagaki H; Ozaki M; Konishi M; Nakagohri T; Takahashi S; Yagi T; Kinoshita T; Tanaka N
Hepatogastroenterology; 2006; 53(67):115-9. PubMed ID: 16506388
[TBL] [Abstract][Full Text] [Related]
12. Serum transforming growth factor-alpha level can be a parameter for evaluating liver regeneration after partial hepatectomy in patients with liver cancer.
Tomiya T; Hayashi S; Yanase M; Umeda N; Tani M; Yamada S; Masaki N; Ogata I; Fujiwara K
Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-14-S6-17. PubMed ID: 9151911
[TBL] [Abstract][Full Text] [Related]
13. Administration of prostaglandin E1 reduces post-operative hepatocellular damage and restores hepatic integrity in patients undergoing hepatectomy.
Baek Y; Nakano H; Kumada K; Nagasaki H; Kigawa G; Sasaki J; Kaneda M; Hatakeyama T; Kitamura N; Sanada Y; Midorikawa T; Yamaguchi M
Hepatogastroenterology; 1999; 46(27):1836-41. PubMed ID: 10430356
[TBL] [Abstract][Full Text] [Related]
14. Alteration in levels of human hepatocyte growth factor following hepatectomy.
Nishizaki T; Takenaka K; Yoshizumi T; Yanaga K; Soejima Y; Shirabe K; Sugimachi K
J Am Coll Surg; 1995 Jul; 181(1):6-10. PubMed ID: 7599773
[TBL] [Abstract][Full Text] [Related]
15. High serum levels of vascular endothelial growth factor after hepatectomy are associated with poor prognosis in hepatocellular carcinoma.
Tamesa T; Iizuka N; Mori N; Okada T; Takemoto N; Tangoku A; Oka M
Hepatogastroenterology; 2009; 56(93):1122-6. PubMed ID: 19760954
[TBL] [Abstract][Full Text] [Related]
16. Profile of hepatocyte growth factor in patients with obstructive jaundice.
Hu RH; Lee PH; Yu SC; Ho MC
Hepatogastroenterology; 2003; 50(54):1987-90. PubMed ID: 14696449
[TBL] [Abstract][Full Text] [Related]
17. Biliary bile acid concentration is a simple and reliable indicator for liver function after hepatobiliary resection for biliary cancer.
Kurumiya Y; Nagino M; Nozawa K; Kamiya J; Uesaka K; Sano T; Yoshida S; Nimura Y
Surgery; 2003 May; 133(5):512-20. PubMed ID: 12773979
[TBL] [Abstract][Full Text] [Related]
18. [Study on the prognostic value of hepatocyte growth factor and c-met for patients with hepatocellular carcinoma].
Wu FS; Zheng SS; Wu LJ; Ding W; Ma ZM; Wang ZM; Teng LS; Zhao WH
Zhonghua Wai Ke Za Zhi; 2006 May; 44(9):603-8. PubMed ID: 16784653
[TBL] [Abstract][Full Text] [Related]
19. Liver functional analysis by total bile acid level of C-tube bile after hepatectomy.
Hotta T; Kobayashi Y; Taniguchi K; Johata K; Sahara M; Ochiai M; Watanabe T; Tanimura H
Hepatogastroenterology; 2005; 52(64):1211-5. PubMed ID: 16001663
[TBL] [Abstract][Full Text] [Related]
20. Weight of resected liver is positively correlated with serum hHGF level.
Miyata K; Taniguchi H; Takeuchi K; Koyama H; Tanaka H; Takahashi T
Hepatogastroenterology; 1996; 43(12):1589-93. PubMed ID: 8975970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
